COMMUNIQUÉS West-GlobeNewswire
-
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
30/03/2026 -
Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment
30/03/2026 -
Anavex Life Sciences Provides Comprehensive Regulatory Update
30/03/2026 -
Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204
30/03/2026 -
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
30/03/2026 -
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
30/03/2026 -
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
30/03/2026 -
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026
30/03/2026 -
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
30/03/2026 -
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
30/03/2026 -
Nordletics App, Reviewed by Nearly 5,000 Users, Expands Home Fitness Reach As Demand For Equipment-Free Wellness Solutions Grows
30/03/2026 -
Bloom Healthcare Launches In-Home Primary Care and Accountable Care Model in Missouri
30/03/2026 -
BiomX Adds Former Mossad Deputy to Advisory Board
30/03/2026 -
Tempest Reports Year End 2025 Financial Results and Provides Business Update
30/03/2026 -
Twig Fertility Brings a New Standard of Patient-Centric Fertility Care to Vancouver
30/03/2026 -
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
30/03/2026 -
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
30/03/2026 -
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
30/03/2026 -
Arch Biopartners Arranges Non-Brokered Private Placement
30/03/2026
Pages